Product Information
BENICAR HCT 40-12.5 MG TABLET is a brand product labeled by Cosette Pharmaceuticals, Inc., priced at $17.2013 per EA under NDC 00713086430. Its NADAC has been published 171 times since Apr 19, 2023.
FDA first approved this application on Jun 5, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5; 40 mg/1; mg/1
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713086430
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/1/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
New Drug (NDA)
FDA Application
NDA021532FDA Approved
6/5/2003
TE Code
AB
On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for BENICAR HCT 40-12.5 MG TABLET has been published 171 times since Apr 19, 2023, and over the history we have for it it has risen 45.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.2013 per EA |
|---|---|
| All-time high | $17.2013 (Jul 22, 2026) |
| All-time low | $11.8211 (Apr 19, 2023) |
| 52-week high | $17.2013 |
| 52-week low | $14.2054 |
| Median price | $14.2054 |
| Average price | $13.9396 |
| Largest weekly change | +10.0% (Sep 25, 2024) |
| Weeks tracked | 171 |
| Tracking since | Apr 19, 2023 |
1W
N/A
1M
N/A
3M
+9.9%
6M
+10.0%
1Y
+21.1%
3Y
+45.5%
5Y
N/A
All
+45.5%
Last surveyed Jul 22, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olmesartan medoxomil-hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BENICAR HCT 40-12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENICAR HCT 40-12.5 MG TABLET, manufactured by Cosette Pharmaceuticals, Inc., is $17.2013 per EA (NDC 00713086430), effective Jul 22, 2026.
How has the price of BENICAR HCT 40-12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENICAR HCT 40-12.5 MG TABLET has risen 45.5%. It has been tracked across 171 weekly CMS publications since Apr 19, 2023.
What are the highest and lowest recorded NADAC prices for BENICAR HCT 40-12.5 MG TABLET?
Since Apr 19, 2023, the NADAC for BENICAR HCT 40-12.5 MG TABLET has ranged from a low of $11.8211 (Apr 19, 2023) to a high of $17.2013 (Jul 22, 2026), with a median of $14.2054 per EA.
Are there cheaper alternatives to BENICAR HCT 40-12.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BENICAR HCT 40-12.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BENICAR HCT 40-12.5 MG TABLET?
BENICAR HCT 40-12.5 MG TABLET (NDC 00713086430) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a brand product.